ATE238767T1 - Antibakterielle wässerige ophtalmische formulierungen mit ofloxacin und chitosan - Google Patents

Antibakterielle wässerige ophtalmische formulierungen mit ofloxacin und chitosan

Info

Publication number
ATE238767T1
ATE238767T1 AT00111377T AT00111377T ATE238767T1 AT E238767 T1 ATE238767 T1 AT E238767T1 AT 00111377 T AT00111377 T AT 00111377T AT 00111377 T AT00111377 T AT 00111377T AT E238767 T1 ATE238767 T1 AT E238767T1
Authority
AT
Austria
Prior art keywords
ofloxacin
chitosan
ophtalmic
formulations
antibacterial aqueous
Prior art date
Application number
AT00111377T
Other languages
English (en)
Inventor
Robert Gurny
Olivia Mireille Felt
Original Assignee
Medidom Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medidom Lab filed Critical Medidom Lab
Application granted granted Critical
Publication of ATE238767T1 publication Critical patent/ATE238767T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT00111377T 2000-05-26 2000-05-26 Antibakterielle wässerige ophtalmische formulierungen mit ofloxacin und chitosan ATE238767T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00111377A EP1157688B1 (de) 2000-05-26 2000-05-26 Antibakterielle wässerige ophtalmische Formulierungen mit Ofloxacin und Chitosan

Publications (1)

Publication Number Publication Date
ATE238767T1 true ATE238767T1 (de) 2003-05-15

Family

ID=8168851

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00111377T ATE238767T1 (de) 2000-05-26 2000-05-26 Antibakterielle wässerige ophtalmische formulierungen mit ofloxacin und chitosan

Country Status (11)

Country Link
US (1) US6589999B2 (de)
EP (1) EP1157688B1 (de)
AT (1) ATE238767T1 (de)
BR (1) BR0102138B1 (de)
CA (1) CA2346631C (de)
CZ (1) CZ299195B6 (de)
DE (1) DE60002448T2 (de)
DK (1) DK1157688T3 (de)
ES (1) ES2195819T3 (de)
PL (1) PL201564B1 (de)
PT (1) PT1157688E (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716970B2 (en) * 2000-04-21 2004-04-06 Adjuvant Pharmaceuticals, Llc Water soluble, randomly substituted partial N-partial O-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof
US7125967B2 (en) * 2003-10-08 2006-10-24 Adjuvant Pharmaceuticals, Llc Water-soluble chitosan having low endotoxin concentration and methods for making and using the same
US7125122B2 (en) * 2004-02-02 2006-10-24 Sharp Laboratories Of America, Inc. Projection system with corrective image transformation
WO2007002345A2 (en) * 2005-06-21 2007-01-04 Bausch & Lomb Incorporated Method for improving water solubility of chitosan
CN100350978C (zh) * 2005-07-12 2007-11-28 何伟 可载药的降解型泪道栓子及其制备方法
FR3016882A1 (fr) 2014-01-30 2015-07-31 Sofradim Production Procede de preparation de chitosane a haut degre d’acetylation
CN108348516B (zh) * 2015-10-29 2021-02-12 特一华制药株式会社 外用剂
CN109846820B (zh) * 2019-04-09 2020-09-29 广东三蓝药业股份有限公司 一种氧氟沙星滴眼液及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH675535A5 (de) * 1988-11-28 1990-10-15 Nestle Sa
US5422116A (en) * 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
EP1128809B1 (de) * 1998-11-20 2004-12-29 Laboratoire Medidom S.A. Wässrige ophthalmische formulierungen mit chitosan

Also Published As

Publication number Publication date
BR0102138B1 (pt) 2013-03-19
PL201564B1 (pl) 2009-04-30
US20020002148A1 (en) 2002-01-03
PT1157688E (pt) 2003-08-29
PL347735A1 (en) 2001-12-03
BR0102138A (pt) 2002-03-12
DK1157688T3 (da) 2003-08-25
CA2346631A1 (en) 2001-11-26
ES2195819T3 (es) 2003-12-16
CA2346631C (en) 2008-12-02
DE60002448T2 (de) 2004-03-25
US6589999B2 (en) 2003-07-08
CZ20011784A3 (cs) 2002-02-13
EP1157688A1 (de) 2001-11-28
EP1157688B1 (de) 2003-05-02
DE60002448D1 (de) 2003-06-05
CZ299195B6 (cs) 2008-05-14

Similar Documents

Publication Publication Date Title
WO2002051464A3 (en) Antimicrobial medical devices
LV10688A (lv) Pretalergisks sastavs oftalmologijai vai deguna slimibam
WO2003010138A3 (en) Piperidine derivatives as antibacterial agents
ATE348826T1 (de) Aminopiperidin chinoline und ihre azaisosteren analoga mit antibakterieller wirkung
TR200302105T4 (tr) Siklosporin, hiyalüronik asit ve polisorbat içeren göz formülasyonları.
ATE327231T1 (de) Chinolinderivate als antibakterielle mittel
MY125356A (en) Moxifloxacin/sodium chloride formulation
NO20032324D0 (no) Vandige desinfeksjonssystemer
CA2309172A1 (en) Aminobiguanides to disinfect contact lenses and preserve pharmaceutical compositions
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
GR3032116T3 (en) A method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans
DE60002448D1 (de) Antibakterielle wässerige ophtalmische Formulierungen mit Ofloxacin und Chitosan
WO2003082926A3 (en) Antimicrobial polymer conjugates
AU2003294565A1 (en) Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
DK1128809T3 (da) Vandige oftalmiske formuleringer omfattende chitosan
WO2001040473A3 (en) Pseudomonas aeruginosa antigens
BR0210632A (pt) Tratamento de doença parasìtica
SE0001916D0 (sv) Novel formulation
WO2002000208A3 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
KR20030009540A (ko) 방부제
RU2001100069A (ru) Антгельминтное средство
WO2004060379A3 (en) Pharmaceutical compositions comprising an antibacterial agent nd antifungal agent and a nitroimidazole for the treatment and prevention of genitourinary infections and their extragenital complications
SE9902674D0 (sv) New composition
WO2002002115A3 (de) Anthelmintika zur verhinderung von parasitären infektionen bei mensch und tier
WO2002002089A3 (de) Anthelminthika zur verhinderung von parasitären infektionen bei mensch und tier iv

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1157688

Country of ref document: EP